Experimental data from FAP-Exd (AVA6103) demonstrates a more favorable profile compared to the marketed Antibody Drug Conjugate (ADC) ...

Increased risk of hyperglycemia in patients with advanced urothelial cancer treated with enfortumab vedotin: A systematic review and meta-analysis. Disitamab vedotin combined with fruquintinib in ...

Alfa Cytology offers specialized radiolabeling and antibody-radionuclide conjugate development to advance radiopharmaceutical and nuclear medicine research.

ADCs combine antibodies with drug payloads for targeted therapy, but complex manufacturing requires monitoring CQAs across multiple entities.

Epidemiology and Infection, Vol. 140, No. 8 (AUGUST 2012), pp. 1343-1355 (13 pages) Global coverage of infant Haemophilus influenzae type b (Hib) vaccination has increased considerably during the past ...

The report identifies key opportunities in Antibody-Drug Conjugates through insights on past trends, drug pipelines, and leading companies. It serves investors, new entrants, and pharma firms looking ...

TORONTO--(BUSINESS WIRE)--AB SCIEX and Dalton Pharma Services (Dalton) announced today a research collaboration to develop Antibody-Drug Conjugate (ADC) analysis capabilities. This will include ...

Driven by the success of 14 approved antibody drug conjugates (ADCs) and a promising developmental pipeline, the field of ADCs has gained significant traction and are anticipated to capture a notable ...